Dynamics at the serine loop underlie differential affinity of cryptochromes for CLOCK:BMAL1 to control circadian timing

  1. Jennifer L Fribourgh
  2. Ashutosh Srivastava
  3. Colby R Sandate
  4. Alicia K Michael
  5. Peter L Hsu
  6. Christin Rakers
  7. Leslee T Nguyen
  8. Megan R Torgrimson
  9. Gian Carlo G Parico
  10. Sarvind Tripathi
  11. NIng Zheng
  12. Gabriel C Lander
  13. Tsuyoshi Hirota
  14. Florence Tama  Is a corresponding author
  15. Carrie L Partch  Is a corresponding author
  1. UCSC, United States
  2. Nagoya University, Japan
  3. Scripps Research Institute, United States
  4. University of Washington, United States
  5. Kyoto University, Japan

Abstract

Mammalian circadian rhythms are generated by a transcription-based feedback loop in which CLOCK:BMAL1 drives transcription of its repressors (PER1/2, CRY1/2), which ultimately interact with CLOCK:BMAL1 to close the feedback loop with ~24-hour periodicity. Here we pinpoint a key difference between CRY1 and CRY2 that underlies their differential strengths as transcriptional repressors. Both cryptochromes bind the BMAL1 transactivation domain similarly to sequester it from coactivators and repress CLOCK:BMAL1 activity. However, we find that CRY1 is recruited with much higher affinity to the PAS domain core of CLOCK:BMAL1, allowing it to serve as a stronger repressor that lengthens circadian period. We discovered a dynamic serine-rich loop adjacent to the secondary pocket in the photolyase homology region (PHR) domain that regulates differential binding of cryptochromes to the PAS domain core of CLOCK:BMAL1. Notably, binding of the co-repressor PER2 remodels the serine loop of CRY2, making it more CRY1-like and enhancing its affinity for CLOCK:BMAL1.

Data availability

Diffraction data have been deposited in PDB under the accession code 6OF7.

The following data sets were generated

Article and author information

Author details

  1. Jennifer L Fribourgh

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Ashutosh Srivastava

    Institute of Transformative Bio-Molecules, Nagoya University, Nagoya, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9820-720X
  3. Colby R Sandate

    Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8758-5931
  4. Alicia K Michael

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Peter L Hsu

    Pharmacology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Christin Rakers

    Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5668-6844
  7. Leslee T Nguyen

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Megan R Torgrimson

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Gian Carlo G Parico

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Sarvind Tripathi

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6959-0577
  11. NIng Zheng

    Pharmacology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Gabriel C Lander

    Structural Biology, Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4921-1135
  13. Tsuyoshi Hirota

    Institute of Transformative Bio-Molecules, Nagoya University, Nagoya, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4876-3608
  14. Florence Tama

    Institute of Transformative bio-Molecules, Nagoya University, Nagoya, Japan
    For correspondence
    florence.tama@nagoya-u.jp
    Competing interests
    The authors declare that no competing interests exist.
  15. Carrie L Partch

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    For correspondence
    cpartch@ucsc.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4677-2861

Funding

National Institutes of Health (R01 GM107069)

  • Carrie L Partch

National Institutes of Health (F31 CA189660)

  • Alicia K Michael

National Institutes of Health (S10 OD021634)

  • Gabriel C Lander

UC Cancer Research Coordinating Committee (CRN-15-380548)

  • Carrie L Partch

National Institutes of Health (DP2 EB020402)

  • Gabriel C Lander

RIKEN (Dynamic Structural Biology Project)

  • Florence Tama

Pew Charitable Trusts (Pew Scholar)

  • Gabriel C Lander

Amgen (Young Investigator)

  • Gabriel C Lander

UC Office of the President (Chancellor's Postdoctoral Fellow)

  • Jennifer L Fribourgh

National Science Foundation (Graduate Research Fellowship)

  • Colby R Sandate

Howard Hughes Medical Institute (Gilliam fellowship)

  • Christin Rakers

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Fribourgh et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,975
    views
  • 488
    downloads
  • 57
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jennifer L Fribourgh
  2. Ashutosh Srivastava
  3. Colby R Sandate
  4. Alicia K Michael
  5. Peter L Hsu
  6. Christin Rakers
  7. Leslee T Nguyen
  8. Megan R Torgrimson
  9. Gian Carlo G Parico
  10. Sarvind Tripathi
  11. NIng Zheng
  12. Gabriel C Lander
  13. Tsuyoshi Hirota
  14. Florence Tama
  15. Carrie L Partch
(2020)
Dynamics at the serine loop underlie differential affinity of cryptochromes for CLOCK:BMAL1 to control circadian timing
eLife 9:e55275.
https://doi.org/10.7554/eLife.55275

Share this article

https://doi.org/10.7554/eLife.55275

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Assmaa Elsheikh, Camden M Driggers ... Show-Ling Shyng
    Research Article

    Pancreatic KATP channel trafficking defects underlie congenital hyperinsulinism (CHI) cases unresponsive to the KATP channel opener diazoxide, the mainstay medical therapy for CHI. Current clinically used KATP channel inhibitors have been shown to act as pharmacochaperones and restore surface expression of trafficking mutants; however, their therapeutic utility for KATP trafficking-impaired CHI is hindered by high affinity binding, which limits functional recovery of rescued channels. Recent structural studies of KATP channels employing cryo-electron microscopy (cryoEM) have revealed a promiscuous pocket where several known KATP pharmacochaperones bind. The structural knowledge provides a framework for discovering KATP channel pharmacochaperones with desired reversible inhibitory effects to permit functional recovery of rescued channels. Using an AI-based virtual screening technology AtomNet followed by functional validation, we identified a novel compound, termed Aekatperone, which exhibits chaperoning effects on KATP channel trafficking mutations. Aekatperone reversibly inhibits KATP channel activity with a half-maximal inhibitory concentration (IC50) ~9 μM. Mutant channels rescued to the cell surface by Aekatperone showed functional recovery upon washout of the compound. CryoEM structure of KATP bound to Aekatperone revealed distinct binding features compared to known high affinity inhibitor pharmacochaperones. Our findings unveil a KATP pharmacochaperone enabling functional recovery of rescued channels as a promising therapeutic for CHI caused by KATP trafficking defects.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Andrew P Latham, Longchen Zhu ... Bin Zhang
    Research Article

    The phase separation of intrinsically disordered proteins is emerging as an important mechanism for cellular organization. However, efforts to connect protein sequences to the physical properties of condensates, that is, the molecular grammar, are hampered by a lack of effective approaches for probing high-resolution structural details. Using a combination of multiscale simulations and fluorescence lifetime imaging microscopy experiments, we systematically explored a series of systems consisting of diblock elastin-like polypeptides (ELPs). The simulations succeeded in reproducing the variation of condensate stability upon amino acid substitution and revealed different microenvironments within a single condensate, which we verified with environmentally sensitive fluorophores. The interspersion of hydrophilic and hydrophobic residues and a lack of secondary structure formation result in an interfacial environment, which explains both the strong correlation between ELP condensate stability and interfacial hydrophobicity scales, as well as the prevalence of protein-water hydrogen bonds. Our study uncovers new mechanisms for condensate stability and organization that may be broadly applicable.